Why do older adults decline participation in research? Results from two deprescribing clinical trials
- PMID: 37464431
- PMCID: PMC10353211
- DOI: 10.1186/s13063-023-07506-7
Why do older adults decline participation in research? Results from two deprescribing clinical trials
Abstract
Background: Heterogenous older adult populations are underrepresented in clinical trials, and their participation is necessary for interventions that directly target them. The purpose of this study was to evaluate reasons why hospitalized older adults declined participation in two deprescribing clinical trials.
Methods: We report enrollment data from two deprescribing trials, Shed-MEDS (non-Veterans) and VA DROP (Veterans). For both trials, inclusion criteria required participants to be hospitalized, age 50 or older, English-speaking, and taking five or more home medications. Eligible patients were approached for enrollment while hospitalized. When an eligible patient or surrogate declined participation, the reason(s) were recorded and subsequently analyzed inductively to develop themes, and a chi-square test was used for comparison (of themes between Veterans and non-Veterans).
Results: Across both trials, 1226 patients (545 non-Veterans and 681 Veterans) declined enrollment and provided reasons, which were condensed into three themes: (1) feeling overwhelmed by their current health status, (2) lack of interest or mistrust of research, and (3) hesitancy to participate in a deprescribing study. A greater proportion of Veterans expressed a lack of interest or mistrust in research (42% vs 26%, chi-square value = 36.72, p < .001), whereas a greater proportion of non-Veterans expressed feeling overwhelmed by their current health status (54% vs 35%, chi-square value = 42.8 p < 0.001). Across both trials, similar proportion of patients expressed hesitancy to participate in a deprescribing study, with no significant difference between Veterans and non-Veterans (23% and 21%).
Conclusions: Understanding the reasons older adults decline participation can inform future strategies to engage this multimorbid population.
Keywords: Deprescribing; Patient engagement; Polypharmacy.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Update of
-
Why do Older Adults Decline Participation in Research? Results from Two Deprescribing Clinical Trials.Res Sq [Preprint]. 2023 Apr 28:rs.3.rs-2814339. doi: 10.21203/rs.3.rs-2814339/v1. Res Sq. 2023. Update in: Trials. 2023 Jul 18;24(1):456. doi: 10.1186/s13063-023-07506-7. PMID: 37163030 Free PMC article. Updated. Preprint.
Similar articles
-
Why do Older Adults Decline Participation in Research? Results from Two Deprescribing Clinical Trials.Res Sq [Preprint]. 2023 Apr 28:rs.3.rs-2814339. doi: 10.21203/rs.3.rs-2814339/v1. Res Sq. 2023. Update in: Trials. 2023 Jul 18;24(1):456. doi: 10.1186/s13063-023-07506-7. PMID: 37163030 Free PMC article. Updated. Preprint.
-
A virtual breakthrough series collaborative to support deprescribing interventions across Veterans Affairs healthcare settings.J Am Geriatr Soc. 2023 Sep;71(9):2935-2945. doi: 10.1111/jgs.18474. Epub 2023 Jun 19. J Am Geriatr Soc. 2023. PMID: 37337658
-
The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial.JAMA Intern Med. 2022 Mar 1;182(3):265-273. doi: 10.1001/jamainternmed.2021.7429. JAMA Intern Med. 2022. PMID: 35040926 Free PMC article. Clinical Trial.
-
A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy.Int J Pharm Pract. 2023 Jun 30;31(4):349-368. doi: 10.1093/ijpp/riad025. Int J Pharm Pract. 2023. PMID: 37155330
-
The value of deprescribing in older adults with dementia: a narrative review.Expert Rev Clin Pharmacol. 2021 Nov;14(11):1367-1382. doi: 10.1080/17512433.2021.1961576. Epub 2021 Aug 19. Expert Rev Clin Pharmacol. 2021. PMID: 34311630 Review.
Cited by
-
Enhancing patient participation in discharge medication communication: a feasibility pilot trial.BMJ Open. 2024 Sep 26;14(9):e083462. doi: 10.1136/bmjopen-2023-083462. BMJ Open. 2024. PMID: 39327052 Free PMC article. Clinical Trial.
-
Feasibility of a theory-based intervention towards benzodiazepine deprescribing in Belgian nursing homes: protocol of the END-IT NH cluster-randomised controlled trial.BMJ Open. 2024 Oct 22;14(10):e085435. doi: 10.1136/bmjopen-2024-085435. BMJ Open. 2024. PMID: 39438099 Free PMC article.
-
Engaging nursing home residents in clinical research: insights from a patient advisory board, a patient advocate, and a study team.Res Involv Engagem. 2024 Oct 28;10(1):111. doi: 10.1186/s40900-024-00648-1. Res Involv Engagem. 2024. PMID: 39468574 Free PMC article.
-
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourth-Year PharmD Undergraduates from Riyadh, Saudi Arabia.Med Sci Monit. 2024 Apr 27;30:e943468. doi: 10.12659/MSM.943468. Med Sci Monit. 2024. PMID: 38676293 Free PMC article.
-
Patient engagement in radiation oncology: a large retrospective study of survey response dynamics.Front Oncol. 2025 Jan 17;14:1434949. doi: 10.3389/fonc.2024.1434949. eCollection 2024. Front Oncol. 2025. PMID: 39896192 Free PMC article.
References
-
- DeCuir-Gunby JT, DeVance Taliaferro J, Greenfield D. Educators’ perspectives on culturally relevant programs for academic success: the American excellence association. Educ Urban Soc. 2010;42(2):182–204. doi: 10.1177/0013124509349874. - DOI
-
- Domecq JP, Prutsky G, Leppin A, Sonbol MB, Altayar O, Undavalli C, Wang Z, Elraiyah T, Brito JP, Mauck KF, Lababidi MH, Prokop LJ, Asi N, Wei J, Fidahussein S, Montori VM, Murad MH. Drugs commonly associated with weight change: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(2):363–370. doi: 10.1210/jc.2014-3421. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources